Citations

Clear

585 citation(s) found for "Tran, Ha".

CADD-48. microRNA-34a PACKAGED IN BACTERIAL NANOCELLS OVERCOMES THERAPEUTIC RESISTANCE IN GLIOBLASTOMA
Khan, Muhammad Babar , Ruggieri, Rosamaria, MacDiarmid, Jennifer A. , Brahmbhatt, Himanshu , Boockvar, John A. , Symons, Marc , Tran, Nhan L. , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi282-vi282

10.1093/neuonc/noy148.1176 Get It

RDNA-06. A NOVEL ROLE OF SGEF IN MEDIATING GBM CELL SURVIVAL BY MODULATING THE DNA DAMAGE REPAIR MECHANISM
Tuncali, Serdar, Sereduk, Christopher, Ensign, Shannon P. Fortin , Kloss, Jean , Loftus, Joseph C. , Ensign, Shannon P. Fortin , Sereduk, Chris , Sarkaria, Jann N. , Tran, Nhan L.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi222-vi223

10.1093/neuonc/noy148.922 Get It

DRES-20. THE TNF RECEPTOR FAMILY MEMBER Fn14 IS HIGHLY EXPRESSED IN RECURRENT GLIOBLASTOMA (GBM) AND IN GBM PATIENT-DERIVED XENOGRAFTS WITH ACQUIRED TEMOZOLOMIDE RESISTANCE
Heath, Jonathan E., Woodworth, Graeme F., Winkles, Jeffrey A. , Hersh, David S. , Tran, Nhan L. , Woodworth, Graeme F

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi79-vi80

10.1093/neuonc/noy148.327 Get It

CSIG-05. PI3K INHIBITORS PX-866 AND BEZ235 DIFFERENTIALLY MODULATE AUTOPHAGY IN GBM
Harder, Bryan , Sereduk, Christopher, Sereduk, Chris , Tran, Nhan L.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi43-vi44

10.1093/neuonc/noy148.171 Get It

DDIS-25. TARGETING GLIOBLASTOMA HETEROGENEITY WITH miR-34a
Khan, Muhammad Babar , Ruggieri, Rosamaria, MacDiarmid, Jennifer A. , Brahmbhatt, Himanshu , Boockvar, John A. , Symons, Marc , Tran, Nhan L. , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi74-vi74

10.1093/neuonc/noy148.304 Get It

NIMG-12. RADIOGENOMICS ON VENUS AND MARS: IMPACT OF SEX-DIFFERENCES ON MRI AND GENETIC CORRELATIONS IN GLIOBLASTOMA
Hu, Leland , Gaw, Nathan , Yoon, Hyunsoo , Eschbacher, Jennifer , Smith, Kris A. , Karis, John P. , Whitmire, Paula , Singleton, Kyle , Jackson, Pamela , Bendok, Bernard R. , Mitchell, J. Ross , Li, Jing , Baxter, Leslie C. , Nakaji, Peter , Hawkins‐Daarud, Andrea , Massey, Susan Christine , Wu, Teresa , Tran, Nhan L. , Rubin, Joshua B , Swanson, Kristin R

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi178-vi178

10.1093/neuonc/noy148.739 Get It

TMOD-18. THE PATIENT DERIVED XENOGRAFT NATIONAL RESOURCE: A COMPREHENSIVE COLLECTION OF HIGH-GRADE GLIOMA MODELS FOR PRE-CLINICAL AND TRANSLATIONAL STUDIES
Tian, Shulan , Peng, Sen, Carlson, Brett L. , Kitange, Gaspar J. , Evers, Lisa, Decker, Paul A. , Kosel, Matthew , Klee, Eric W. , James, C. David , Eckel‐Passow, Jeanette E. , Verhaak, Roel G.W. , Jenkins, Robert B. , Vaubel, Rachael A. , Remonde, Dioval , Schroeder, Mark A. , Kollmeyer, Thomas M. , Mladek, Ann C. , Daniel, J. , Decker, Paul A. , Berens, Michael E. , Califano, Andrea , Lachance, Daniel Honore , Sulman, Erik P. , Tran, Nhan L. , Giannini, Caterina , Parney, Ian F. , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi272-vi272

10.1093/neuonc/noy148.1130 Get It

ANGI-02. A CRITICAL ROLE FOR LARG IN RhoC MEDIATED GLIOBLASTOMA CELL INVASION
Dong, Zhiwan , Ensign, Shannon P. Fortin , Sabit, Hemragul, Ruggieri, Rosamaria, Symons, Marc , Loftus, Joseph C. , Ensign, Shannon P. Fortin , Ding, Zonghui , Yang, Yuping , Nakada, Mitsutoshi , Tran, Nhan L.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi28-vi28

10.1093/neuonc/noy148.104 Get It

Mitochondrial ATP synthase β‐subunit production rate and ATP synthase specific activity are reduced in skeletal muscle of humans with obesity
Tran, Lee , Langlais, Paul R. , Hoffman, Nyssa, Roust, Lori R., Katsanos, Christos S. , Katsanos, Christos S

Mayo Clinic

Experimental Physiology | October 26, 2018 | Volume: 104 | Issue: 1 | Pages: 126-135

10.1113/ep087278 | PMID 30362197 Get It

New Findings What is the central question of this study? Humans with obesity have lower ATP synthesis in muscle along with lower content of the β‐subunit of the ATP synthase (β‐F1‐ATPase), the catalytic component of the ATP synthase. Does lower synthesis rate of β‐F1‐ATPase in muscle contribute to these responses in humans with obesity? What is the main finding and its importance? Humans with obesity have a lower synthesis rate of β‐F1‐ATPase and ATP synthase specific activity in muscle. These findings indicate that reduced production of subunits forming the ATP synthase in muscle may contribute to impaired generation of ATP in obesity. AbstractThe content of the β‐subunit of the ATP synthase (β‐F1‐ATPase), which forms the catalytic site of the enzyme ATP synthase, is reduced in muscle of obese humans, along with a reduced capacity for ATP synthesis. We studied 18 young (37 ± 8 years) subjects of which nine were lean (BMI = 23 ± 2 kg m−2) and nine were obese (BMI = 34 ± 3 kg m−2) to determine the fractional synthesis rate (FSR) and gene expression of β‐F1‐ATPase, as well as the specific activity of the ATP synthase. FSR of β‐F1‐ATPase was determined using a combination of isotope tracer infusion and muscle biopsies. Gene expression of β‐F1‐ATPase and specific activity of the ATP synthase were determined in the muscle biopsies. When compared to lean, obese subjects had lower muscle β‐F1‐ATPase FSR (0.10 ± 0.05 vs. 0.06 ± 0.03% h−1; P < 0.05) and protein expression (P < 0.05), but not mRNA expression (P > 0.05). Across subjects, abundance of β‐F1‐ATPase correlated with the FSR of β‐F1‐ATPase (P < 0.05). The specific activity of muscle ATP synthase was lower in obese compared to lean subjects (0.035 ± 0.004 vs. 0.042 ± 0.007 arbitrary units; P < 0.05), but this difference was not significant after the activity of the ATP synthase was adjusted to the β‐F1‐ATPase content (P > 0.05). Obesity impairs the synthesis of β‐F1‐ATPase in muscle at the translational level, reducing the content of β‐F1‐ATPase in parallel with reduced capacity for ATP generation via the ATP synthase complex.